Delivery Order SPE2DR25D1103-SPE2DR26FD689
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,578.50 on August 4, 2025, for the supply of Methamphetamine HCL tablets (5mg). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4557920466 - Methamphetamine 5 mg Tablets, 100s, with a ceiling value of $4,492.19 and a period of performance through July 27, 2022. The contract is a Firm Fixed Price (FFP) Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,025.90 to AmerisourceBergen Drug Corp for the supply of Amphetamine Sulfate 10 mg tablets in quantities of 100 on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,635.62, is for the delivery of Methamphetamine HCL Tablets 5mg. This is a Firm Fixed Price Delivery Order contract with a completion date of February 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,699.02 firm fixed-price delivery order is for the supply of 4557681066 methamphetamine 5 mg tablets in 100-count bottles. The contract has an ultimate completion date of June 29, 2022 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,175.69, is for the delivery of methamphetamine hydrochloride tablets, 5mg, with a completion date of December 10, 2024. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 5 mg tablets (100 count) valued at $1,107.73 on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Amphetamine Mix Tablets 20mg. This competitively awarded, non-set-aside contract carries a ceiling value of $1,247.04 with a firm fixed price structure and an ultimate completion date of October 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100 count) on September 4, 2025, with a ceiling value of $1,034.62 and completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100s, with a ceiling value of $4,627.63 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD689Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Methamphetamine 5 mg tablets in quantities of 100 units. This competitive, non-set-aside contract carries a ceiling value of $3,677.92 and a firm fixed price structure, with an ultimate completion date of October 31, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement that runs through December 2026 and supports global military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to execute this requirement given its extensive federal procurement experience and critical role in supplying medications to Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates consistent capability in delivering controlled substances, specialty medications, and diverse pharmaceutical products across multiple therapeutic domains. This delivery order represents one of numerous transactions executed under the company's primary DLA vehicle, which provides flexible access to a comprehensive range of pharmaceutical products and medical supplies supporting worldwide military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/30/25 |